Healthcare Finance
Covers the role of finance in the biotech and pharmaceutical industries; specifically, the application of novel financing methods and business structures to facilitate drug discovery, clinical development, and greater patient access to high-cost therapies. Topics include basic financial analysis for the life-sciences professional; risks and returns in the biopharma industries; the mechanics of biotech startup financing; capital budgeting for biopharma companies; and applications of financial engineering in modern healthcare investment strategies and institutions. Develops a systemic framework for addressing the biggest challenges in the biomedical ecosystem. Enrollment may be limited; preference to Sloan graduate students.
Spring 2019 · Healthcare Finance (15.482x)
Healthcare Finance (15.482x) provides students with the background, resources, and framework to influence the healthcare industry. Topics include applying financial techniques such as portfolio theory, securitization, and option pricing to biomedical contexts to develop more efficient funding structures to reduce financial risks, lower the cost of capital, and bring more life-saving therapies to patients faster. As part of the {{% resource_link "853fbd95-1d3e-4d7d-b4a7-d70b1be75802" "Open Learning Library" %}}, this course is free to use. You have the option to sign up and enroll if you want to track your progress, or you can view and use all the materials without enrolling.
Prerequisites & course information
Prereq: 15.401 , 15.414 , 15.415 , or permission of instructor G (Spring) 3-0-6 units
Sources
- Course catalogue ↗2026–2027
- MIT OpenCourseWare ↗Spring 2019
- Historical MIT OpenCourseWare offering. Named reading entries and schedule topics are automatically extracted from the linked source pages.